Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121695) titled 'Multimodal Integration for Efficacy Prediction and Prognostic Assessment in Immunotherapy-Treated Lung Cancer: A Multicenter Cohort Study' on April 1.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Condition:
Lung Cancer
Intervention:
Pathological Response Group (Cohort A):None
Progressive Advanced Lung Cancer Group (Cohort B):None
Non-Progressive Advanced Lung Cancer Group (Cohort B):None
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-01
Target Sample Siz...